Rate control for atrial fibrillation (AFib) is a treatment approach that slows down the heartbeat when the heart beats too quickly or irregularly. It helps the lower chambers of the heart beat at a more manageable speed, which can reduce symptoms and help protect the heart from problems caused by a persistently fast heart rate. Unlike rhythm control, rate control does not aim to restore a normal heart rhythm.
How Does Rate Control Work in Atrial Fibrillation?
To understand rate control, it helps to know what happens during atrial fibrillation. The heart has four chambers. The two upper chambers are called the atria, and the two lower chambers are called the ventricles.
Normally, electrical signals travel through the heart in an organized pattern, allowing the chambers to contract in the correct order. During AFib, the atria receive disorganized electrical signals and quiver instead of contracting in a steady rhythm.
Some of these electrical signals pass through a structure called the atrioventricular (AV) node, which connects the upper and lower chambers. When too many signals reach the ventricles, the lower chambers can beat very quickly and irregularly.
Rate control medicines slow the passage of electrical signals through the AV node. This helps prevent the ventricles from beating excessively fast, even though the atria may continue to have an irregular rhythm.
The Cleveland Clinic explains that AFib involves disorganized electrical activity in the upper chambers, which also affects how the lower chambers contract. Rate control focuses on managing the response of the lower chambers.
Why Is Rate Control Used for AFib?
The main purpose of rate control is to make the heart beat at a speed that is more comfortable and appropriate for the body's needs. A persistently rapid heart rate can make everyday activities more difficult and, in some cases, affect how well the heart pumps blood.
Rate control may help to:
- Reduce uncomfortable sensations such as a racing or pounding heartbeat.
- Improve symptoms such as breathlessness, fatigue, and reduced ability to exercise when these are related to a fast heart rate.
- Reduce the strain associated with a persistently rapid heartbeat.
- Help prevent or manage weakening of the heart muscle associated with a prolonged rapid heart rate.
- Make it easier to carry out normal daily activities.
According to the 2023 American College of Cardiology, American Heart Association, American College of Clinical Pharmacy, and Heart Rhythm Society guideline, the goals of rate control include managing symptoms and reducing the risk of problems with the heart's pumping function.
Which Medications Are Used for Rate Control?
Several types of medicines can slow the heart rate during atrial fibrillation. The choice depends on factors such as heart function, blood pressure, other medical conditions, symptoms, and how well a person responds to treatment.
1. Beta Blockers
Beta blockers are commonly used to slow the heart rate. They reduce the effects of stress hormones, such as adrenaline, on the heart. This helps slow electrical activity and reduces how quickly the ventricles beat.
Examples include:
- Metoprolol
- Bisoprolol
- Atenolol
- Carvedilol
- Propranolol
These medicines may be used for ongoing rate control or to manage a rapid heart rate in an acute care setting. The specific medicine and dose depend on the person's health and treatment needs.
2. Calcium Channel Blockers
Some calcium channel blockers slow electrical signals passing through the AV node. This reduces the speed at which the ventricles beat during AFib.
The two medicines commonly used for this purpose are:
- Diltiazem: Slows electrical conduction through the AV node and helps control the ventricular heart rate.
- Verapamil: Also slows conduction through the AV node, helping reduce the heart rate.
These medicines are not suitable for everyone. In particular, diltiazem and verapamil are generally avoided in people with a reduced left ventricular ejection fraction below 40% because they can worsen heart failure. A healthcare professional considers heart function and blood pressure before prescribing them.
3. Digoxin
Digoxin is another medicine used to slow the heart rate in some people with atrial fibrillation. It affects electrical signals passing through the AV node and can help reduce how quickly the ventricles beat.
It may be considered when other rate-control medicines are not suitable, are not tolerated, or do not provide enough control. It can also be used in selected people with AFib who have symptoms of heart failure.
Digoxin generally controls the heart rate better at rest than during physical activity. For this reason, some people may need another rate-control medicine alongside it.
The Mayo Clinic describes beta blockers, calcium channel blockers, and digoxin as medication options for controlling the speed of the heartbeat. It also explains that digoxin may not control the heart rate as effectively during activity.
What Is the Target Heart Rate During AFib Rate Control?
The target heart rate is the speed healthcare professionals aim to maintain while managing atrial fibrillation. It is not necessarily the same for everyone.
For many adults with AFib who do not have heart failure, current US clinical guidance generally supports an initial resting heart rate target of less than 100 to 110 beats per minute, provided symptoms are appropriately controlled.
This is sometimes called a lenient rate-control approach. It means that treatment does not always need to bring the resting heart rate below 80 beats per minute if a higher rate is well tolerated and other clinical factors are suitable.
However, a lower target may be considered in some situations, including when a person continues to have symptoms or has concerns related to impaired heart function.
The appropriate target depends on several factors:
- Heart rate while resting.
- Heart rate during physical activity.
- Whether symptoms such as breathlessness or fatigue continue.
- Whether the heart's pumping function is affected.
- Other medical conditions and response to medication.
These numbers are treatment targets, not a way to assess AFib or decide independently whether medication is working. The treating clinician determines the appropriate goal based on the overall clinical picture.
Rate Control vs. Rhythm Control: What Is the Difference?
Rate control and rhythm control are two different approaches to managing atrial fibrillation. Both aim to improve heart function and reduce the effects of AFib, but they work in different ways.
| Feature | Rate Control | Rhythm Control |
|---|---|---|
| Main goal | Slow the ventricular heart rate. | Restore or maintain a normal heart rhythm. |
| Heart rhythm | AFib may continue. | Aims to restore a normal rhythm and prevent AFib episodes. |
| Medicines | Beta blockers, diltiazem, verapamil, or digoxin. | Selected antiarrhythmic medicines. |
| Other treatments | Selected cases may involve AV node ablation with pacemaker implantation. | May involve electrical cardioversion or catheter ablation. |
| Primary focus | Control how quickly the ventricles beat. | Control the abnormal electrical rhythm itself. |
For example, someone receiving rate-control treatment may continue to have an irregular heartbeat, but their heart rate may be sufficiently controlled to reduce symptoms. Someone receiving rhythm-control treatment has a different goal: returning the heart to a normal rhythm and helping it stay that way.
The choice between these approaches is individualized. Healthcare professionals consider symptoms, how long AFib has been present, other health conditions, medication risks, and personal treatment preferences.
Does Rate Control Prevent Blood Clots and Stroke?
No. Rate control and stroke prevention are separate parts of atrial fibrillation management.
Rate-control medicines slow the heartbeat, but they do not directly prevent blood clots from forming in the heart. AFib can allow blood to collect in the upper chambers, increasing the possibility of clot formation and stroke.
Some people with AFib are prescribed anticoagulants, commonly called blood thinners, to reduce the risk of blood clots and stroke. Examples include apixaban, rivaroxaban, dabigatran, edoxaban, and warfarin.
The decision to use an anticoagulant is based on an assessment of stroke risk and bleeding risk. Achieving a satisfactory heart rate does not automatically remove the need for anticoagulation.
The American Heart Association distinguishes between medicines that control heart rate, medicines that control heart rhythm, and medicines used to prevent blood clots. These treatments have different purposes and may be prescribed together when appropriate.
How Do Doctors Monitor Rate-Control Treatment?
Rate control is usually assessed over time rather than through a single heart rate measurement. Regular follow-up helps determine whether medication is controlling the heart rate adequately and whether symptoms are improving.
Depending on the situation, monitoring may include:
- Heart rate checks: Measuring the pulse at rest and considering how the heart rate responds to activity.
- Electrocardiogram (ECG): Recording the heart's electrical activity to assess its rate and rhythm.
- Symptom review: Discussing palpitations, fatigue, breathlessness, dizziness, and changes in exercise tolerance.
- Medication review: Assessing whether the prescribed dose is appropriate and whether unwanted effects are occurring.
- Heart function assessment: An echocardiogram may be used when there is a need to assess the heart's structure and pumping function.
The National Health Service (NHS) explains that people receiving AFib treatment have regular check-ups to assess symptom control. The evaluation may include checking the heart rate, recording an ECG, and investigating other possible health factors.
What Happens If Rate-Control Medication Does Not Work?
Sometimes, a person's heart rate remains too fast despite taking medication, or symptoms continue even after treatment has been adjusted. In these situations, the healthcare professional may review the diagnosis, medication choices, doses, and other health conditions that could affect heart rate.
Possible next steps include:
- Adjusting medication: The clinician may change the dose or select another suitable medicine.
- Combining medicines: In selected cases, two rate-control medicines may be used when one does not provide adequate control.
- Considering rhythm control: Cardioversion, antiarrhythmic medicines, or catheter ablation may be discussed when a rhythm-control approach is more suitable.
- Considering AV node ablation and a pacemaker: This is an option for carefully selected people when medication cannot adequately control the ventricular rate and other treatment approaches are unsuitable or unsuccessful.
AV node ablation involves interrupting the electrical connection between the atria and ventricles. Because the ventricles can no longer receive normal electrical signals through this pathway, a pacemaker is needed to maintain their heartbeat. This procedure does not eliminate atrial fibrillation itself.
The choice of further treatment depends on the person's heart function, symptoms, response to medication, and overall health.
When Should Someone Seek Medical Attention?
People receiving rate-control treatment should contact their healthcare professional when they experience persistent or worsening palpitations, increasing breathlessness, unusual fatigue, dizziness, or a noticeable decline in their ability to carry out everyday activities.
Emergency medical attention is important when a fast or irregular heartbeat occurs with chest pain, severe shortness of breath, or fainting. Sudden weakness on one side of the body, difficulty speaking, sudden confusion, or loss of vision can also indicate a possible stroke and require immediate emergency assessment.
Prescribed rate-control medicines should not be stopped or adjusted independently, even when the heartbeat feels normal. Any changes should be discussed with the treating healthcare professional.